Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhao B Kang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature|February 7, 2004
Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acidsJing X Kang, Jingdong Wang, Lin Wu, et al.
Anticancer Research|May 17, 2002
Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cellsYinlin Ge, Zhihong Chen, Zhao B Kang, et al.
Scientific Reports|February 9, 2020
Fluopack screening platform for unbiased cellular phenotype profilingZhao B Kang, Ioannis Moutsatsos, Francesca Moretti, et al.
Journal of Biomolecular Screening|November 20, 2013
Application of Titration-Based Screening for the Rapid Pilot Testing of High-Throughput AssaysJi-Hu Zhang, Zhao B Kang, Ophelia Ardayfio, et al.
Plos One|August 25, 2020
An iron-dependent metabolic vulnerability underlies VPS34-dependence in RKO cancer cellsMarek J Kobylarz, Jonathan M Goodwin, Zhao B Kang, et al.
Journal of Medicinal Chemistry|June 28, 2016
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase InhibitorJorge Garcia Fortanet, Christine Hiu-Tung Chen, Ying-Nan P Chen, et al.
Nature Chemical Biology|January 16, 2019
Discovery of a ZIP7 inhibitor from a Notch pathway screenErin Nolin, Sara Gans, Luis Llamas, et al.
Nature|July 1, 2016
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.
Journal of Medicinal Chemistry|September 10, 2020
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature|February 7, 2004
Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acidsJing X Kang, Jingdong Wang, Lin Wu, et al.
Anticancer Research|May 17, 2002
Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cellsYinlin Ge, Zhihong Chen, Zhao B Kang, et al.
Scientific Reports|February 9, 2020
Fluopack screening platform for unbiased cellular phenotype profilingZhao B Kang, Ioannis Moutsatsos, Francesca Moretti, et al.
Journal of Biomolecular Screening|November 20, 2013
Application of Titration-Based Screening for the Rapid Pilot Testing of High-Throughput AssaysJi-Hu Zhang, Zhao B Kang, Ophelia Ardayfio, et al.
Plos One|August 25, 2020
An iron-dependent metabolic vulnerability underlies VPS34-dependence in RKO cancer cellsMarek J Kobylarz, Jonathan M Goodwin, Zhao B Kang, et al.
Journal of Medicinal Chemistry|June 28, 2016
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase InhibitorJorge Garcia Fortanet, Christine Hiu-Tung Chen, Ying-Nan P Chen, et al.
Nature Chemical Biology|January 16, 2019
Discovery of a ZIP7 inhibitor from a Notch pathway screenErin Nolin, Sara Gans, Luis Llamas, et al.
Nature|July 1, 2016
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.
Journal of Medicinal Chemistry|September 10, 2020
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.
Pageof 1